Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs IV Insulin Glucose Disposal in T1D
NCT00287066Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Feb 2006
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), sponsored by Pfizer. Started Feb 2006; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00287066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287066.